Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harvest Capital Credit was a publicly traded business development company that provided customized financing solutions to privately held small and mid-sized companies in North America. Its investment strategy focused on direct lending and structured credit, including senior secured debt, unitranche loans, junior secured term loans, subordinated debt, and minority equity co-investments. The company was externally managed and operated as a closed-end, non-diversified management investment company that had elected BDC status under the Investment Company Act of 1940. Harvest Capital Credit was not a life science, biotech, pharma, or healthcare operating company; it was a specialty finance vehicle. The company completed a merger into Portman Ridge Finance Corporation on June 9, 2021 and is no longer active as an independent public company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harvest Capital Credit Corporation.